Cancer patients rely on accurate and clinically valid diagnostic tests, which have become increasingly critical in the management of cancer. Historically, diagnostic tests underwent widely different oversight depending on whether they were submitted to the Food and Drug Administration (FDA) for review or were offered as laboratory developed tests (LDTs),